Literature DB >> 1929936

Endothelial protection and viscoelastic retention during phacoemulsification and intraocular lens implantation.

D B Glasser1, D C Osborn, J F Nordeen, Y I Min.   

Abstract

Endothelial protection (measured by vital-dye staining and computerized planimetry) and viscoelastic retention during phacoemulsification with and without traumatic lens implantation were assessed in a rabbit model comparing four viscoelastics (Healon, Amvisc Plus, Occucoat, and Viscoat). No significant differences in cell damage were noted between unoperated on controls and groups that underwent atraumatic phacoemulsification with viscoelastic. Cell damage after traumatic lens insertion was reduced significantly by all four viscoelastics. Cell damage with and without traumatic lens implantation was significantly lower when viscoelastics were retained. Viscoat and Occucoat were significantly more likely to be retained than Healon.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1929936     DOI: 10.1001/archopht.1991.01080100118055

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  5 in total

1.  Corneal toxicity secondary to inadvertent use of benzalkonium chloride preserved viscoelastic material in cataract surgery.

Authors:  H Eleftheriadis; M Cheong; S Sandeman; P P Syam; P Brittain; G K Klintworth; A Lloyd; C Liu
Journal:  Br J Ophthalmol       Date:  2002-03       Impact factor: 4.638

Review 2.  Hyaluronic acid. A review of its pharmacology and use as a surgical aid in ophthalmology, and its therapeutic potential in joint disease and wound healing.

Authors:  K L Goa; P Benfield
Journal:  Drugs       Date:  1994-03       Impact factor: 9.546

3.  Viscoat versus Visthesia during phacoemulsification cataract surgery: corneal and foveal changes.

Authors:  Marilita M Moschos; Irini P Chatziralli; Theodoros N Sergentanis
Journal:  BMC Ophthalmol       Date:  2011-04-29       Impact factor: 2.209

4.  Comparison of corneal endothelial cell loss during phacoemulsification using continuous anterior chamber infusion versus those using ophthalmic viscosurgical device: randomized controlled trial.

Authors:  B K Nayak; Elesh Kumar Jain
Journal:  Indian J Ophthalmol       Date:  2009 Mar-Apr       Impact factor: 1.848

5.  Dispersive viscosurgical devices demonstrate greater efficacy in protecting corneal endothelium in vitro.

Authors:  Timur Mert Yildirim; Gerd U Auffarth; Hyeck-Soo Son; Ramin Khoramnia; Donald John Munro; Patrick R Merz
Journal:  BMJ Open Ophthalmol       Date:  2019-02-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.